45
Sosei Heptares
4565.T·TSETokyo JPFounded 1990200 employees
Small CapbiotechPublicCNSMetabolic
Platform: GPCR Platform
Market Cap
$1B
All Drugs
2
Clinical Trials
4
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (4565.T)
Loading 4565.T stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| 456-7078 | 456-7078 | Phase 1/2 | 2 | TIM-3 | AngelmanEpilepsy | ||
| Rilurelsin | 456-8669 | Phase 1 | 2 | MALT1 | Crohn's |
SEC Filings & Financial Documents
SEC filings are not available for TSE-listed companies.
Sosei Heptares trades on TSE (JP). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)